Dr. John Cush RheumNow
2 years 5 months ago
ICYMI: Teaching and Academic Burnout
RheumNow recently highlighted a publication that reported about a third of physicians in academia intend to leave.
https://t.co/uSVVJ6zl73 https://t.co/6BWwd2btMf
Dr. John Cush RheumNow
2 years 5 months ago
Preoperative Delay & Education Benefits Arthroplasty Patients
A randomized study shows having patients waiting for knee arthroplasty undergo a preoperative program of weight loss, exercise, etc gave them modestly improved pain/function/quality of life.
https://t.co/RSFwhFKq8U https://t.co/xgyQ65mUAO
Dr. John Cush RheumNow
2 years 5 months ago
Stills Dz Rx w/ IL-1 or IL-6 inhib may mask Dx of MAS! Study of 162 systemic JIA & MAS (62 on biologics). Biologic Rx pts had lower Plt, Ferritin (1107 vs 2863(, CRP (15 vs 90), ESR, fever duration. 27% on IL1/IL6i did not meetMAS classification criteria https://t.co/RmAzxh459R https://t.co/SXroqNBLSZ
A Korean nationwide cohort study found that both seropositive and seronegative rheumatoid arthritis (RA) patients have a significantly higher risk of depression.
Depression is one of the most common comorbidities in rheumatic disease patients and it imparts a significant morbidity and mortality risk for those affected.
Dr. John Cush RheumNow
2 years 5 months ago
Can Mycophenolate be Stopped in Stable SLE?
https://t.co/cDmarnHjAN https://t.co/YgG1jbP4Pw
Dr. John Cush RheumNow
2 years 5 months ago
EMR study identified 3.5+ million pts w/ BMI >30 -- 23% had sleep apnea (OSA). OSA had >2 fold risk of gout (7.2% vs 2.8%)vs those without OSA (p<0.0001). The odds of having gout are 2.65 times higher(HR 2.39; (CI) 2.367-2.419, p<0.0001). https://t.co/GgWrAiFPds https://t.co/QuQUk7nwDK
While it is believed that autoimmunity follows autoantibody positivity, a Danish study shows the incidence of polyautoimmunity to be similar in rheumatoid arthritis (RA) patients who are either anticyclic citrullinated peptide antibody (ACPA)–positive or ACPA–negative.
Data was drawn from RA adults in the DANBIO rheumatology register. Polyautoimmunity included 21 nonrheumatic autoimmune diseases.
According to the National Health Interview Survey (NHIS), in 2022, the prevalence of diagnosed arthritis in adults was 18.9% (women 21.5%, more than men 16.1%). These numbers are down since the CDC's MMWR report of 2019–2021, where is was estimated 21.2% of U.S. adults (53.2 million) had "diagnosed arthritis".
Trends show:
Dr. John Cush RheumNow
2 years 5 months ago
COVIDs Extended Risk for Rheumatic Disease
Annals of Internal Medicine reports a large, binational study finding SARS-CoV-2 infection was associated with an increased risk for AIRDs that extends up to 12 months after infection.
https://t.co/AIFc3B2YDP https://t.co/TzP49i6br8
Dr. John Cush RheumNow
2 years 5 months ago
85 pts w/ Myositis by MRI. Abnl MRI patterns correlated w/:
- Honeycomb & foggy w TIF1γ or Mi2+, MSA-neg DM/PM, SRP+, HMGCR+
- Honeycomb w Cancer (OR 6.8), Gottrons(OR 8)
- Foggy w weakness (OR 11.2)
- Dense dot w dysphagia (OR 6.3) & CA https://t.co/kZGuNLFglg https://t.co/lK93U5iY7q
Dr. John Cush RheumNow
2 years 5 months ago
Review of autoimmune Dz & adverse preg outcomes: Incr risk of:
- Miscarriage w/ Sjögrens (RR 8.85) & SLE (OR 4.9)
- Preeclampsia w/ SLE (OR 3.2)
- IUGR w/ scleroderma (OR 3.2) & celiac (OR 1.71)
- Preterm birth w/ SLE (OR 2.79).
https://t.co/PdxJTK6mw3 https://t.co/ToQXgRoEsS
Dr. John Cush RheumNow
2 years 5 months ago
12 Best Hospitals in the USA according to Newsweek
1 Mayo Clinic
2 Cleveland Clinic
3 Johns Hopkins
4 MGH
5 UCLA Med Center
6 Stanford Hospital
7 Brigham & Womens
8 Mount Sinai NYC
9 Northwestern
10 University of Michigan
11 Cedars-Sinai
12 UCSF https://t.co/AJnJsWr4eY https://t.co/M2Abicf4eD
Data from the Global Burden of Diseases Study 2019, suggests that early-onset osteoarthritis (OA) (before age 55 yrs) is an emerging health issue that parallels societal problems of obesity.
Having patients waiting for knee arthroplasty undergo a preoperative program of weight loss, exercise, and other interventions gave them modestly improved pain, function, and quality of life, a small randomized trial showed.
Dr. John Cush RheumNow
2 years 5 months ago
Sandoz has announced FDA approval for their two interchangeable biosimilars of denosumab - Wyost (denosumab-bddz) and Jubbonti (denosumab-bddz) based on reference products Xgeva and Prolia https://t.co/5OmJHDYWmM https://t.co/iHsqlJ9wYl

